Catheter-directed thrombolysis

Catheter-directed thrombolysis (CDT) is an endovascular approach to the treatment of acute iliofemoral deep vein thrombosis. It involves the administration of a lytic agent directly into a thrombus. 

  • precise diagnosis of iliofemoral deep vein thrombosis 
    • first episode of acute iliofemoral DVT
    • symptomatic patients
    • onset of symptoms <14 days
  • low bleed risk
  • ambulatory patients with good functional capacity and acceptable life expectancy
  • phlegmasia cerulea dolens
  • cerebral disease
  • previous ipsilateral DVT
  • uncontrolled hypertension
  • bleeding disorders
  • isolated femoral - popliteal deep vein thrombosis should be managed with conventional anticoagulation therapy

Ultrasound-guided micropuncture technique of a deep vein of the lower limb is performed, usually the popliteal vein. There are a wide range of catheters and they usually have multiple holes employing a pulse-spray technique of the thrombolytic agent.

Recombinant tissue plasminogen activator (rt-PA) is the thrombolytic agent of choice, it has a half life of 3-5 minutes and 90% first pass elimination in the liver. This results in targeted activation of plasminogen on the clot with the intent to dissolve fibrin. Doses range between 1-2 mg/hr up to a total dose of 30 mg. Heparin is used to maintain venous patency. 

Successful catheter-directed thrombolysis results in a patent vein on venogram, spontaneous outflow of injected contrast and disappearance of venous collaterals.


So far studies have shown no mortality or pulmonary embolism associated with catheter-directed thrombolysis. Major bleeding rates are 1-2% while minor bleeding was found to be <25%.



Share article

Article information

rID: 54699
Synonyms or Alternate Spellings:
  • Catheter-directed thrombolysis (CDT)

Support Radiopaedia and see fewer ads

Updating… Please wait.

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.